Fulgent Genetics, Inc. FLGT Laboratory Services — Interest Expense Nonoperating
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating?
- Fulgent Genetics, Inc. (FLGT) reported laboratory services — interest expense nonoperating of $17K in Q1 2026.
- How has Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating changed year-over-year?
- Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating increased by 21.4% year-over-year, from $14K to $17K.
- What is the long-term trend for Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating?
- Over 2 years (2022 to 2025), Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating has grown at a -72.8% compound annual growth rate (CAGR), from $1.01M to $75K.
- What does laboratory services — interest expense nonoperating mean?
- This metric captures the non-operating interest costs incurred by the laboratory services segment, typically related to debt financing or lease obligations. Monitoring this expense is essential for understanding the segment's cost of capital and the impact of leverage on its overall financial performance.